Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
BLCO
)
15.91
+0.44 (+2.84%)
Streaming Delayed Price
Updated: 10:06 AM EDT, Jul 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BLCO
< Previous
1
2
3
4
5
Next >
Analyst Ratings for Bausch & Lomb
July 24, 2023
Via
Benzinga
Bausch + Lomb Will Release Second-Quarter 2023 Financial Results on August 2
July 11, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Expands OTC Eye Care Portfolio, Acquires JNJ's Blink
July 06, 2023
Bausch + Lomb Corporation (NYSE: BLCO) has acquired Johnson & Johnson's (NYSE: JNJ) eye and contact lens drops brand Blink for $106.5 million to bolster its position in over-the-counter (OTC)...
Via
Benzinga
Bausch + Lomb Expands OTC Product Line with Acquisition of Blink® Eye Drops
July 06, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Analyst Ratings for Bausch & Lomb
July 03, 2023
Via
Benzinga
9 Analysts Have This to Say About Bausch & Lomb
May 19, 2023
Via
Benzinga
Looking Into Bausch & Lomb's Return On Capital Employed
May 12, 2023
Via
Benzinga
Bausch & Lomb's Return On Capital Employed Insights
May 09, 2023
Via
Benzinga
Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday
June 30, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Amazon Hires Dozens of Former FTC Officials, Volkswagen Discusses With Tesla to Adopt North American Charging Standard, FDA Approves First Hemophilia A BioMarin Gene Therapy: Today's Top Stories
June 30, 2023
New York Post
Via
Benzinga
Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis
June 30, 2023
Bausch + Lomb Corporation (NYSE: BLCO) has agreed to acquire 'front of eye' ophthalmology assets for $1.75 billion in upfront cash, plus additional milestone payments from Novartis AG (NYSE:
Via
Benzinga
Inflationary Factors And Slow Product Uptake Could Be Headwinds For Bausch + Lomb, Analyst Says
May 08, 2023
Via
Benzinga
Recap: Bausch & Lomb Q1 Earnings
May 03, 2023
Via
Benzinga
Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)
June 30, 2023
Via
ACCESSWIRE
Bausch + Lomb Will Acquire XIIDRA®
June 30, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches PreserVision® AREDS 2 Formula Soft Gels Plus CoQ10 in the United States
June 12, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces New Scientific Data and Analyses Featuring Consumer, Vision Care and Pharmaceutical Products Will Be Presented During American Optometric Association's Optometry's Meeting
June 08, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches Biotrue® Hydration Boost Contact Lens Rehydrating Drops in the United States
June 06, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches Bausch + Lomb INFUSE® Multifocal Silicone Hydrogel Contact Lenses in the United States
June 05, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Key Leadership Changes
June 01, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) for the Treatment of the Signs and Symptoms of Dry Eye Disease
May 18, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces First-Quarter 2023 Results and Provides 2023 Guidance
May 03, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Releases Annual Environmental, Social and Governance Report
May 01, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting
April 26, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results
April 25, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces U.S. Launch of StableVisc™ Cohesive Ophthalmic Viscosurgical Device and TotalVisc™ Viscoelastic System
April 24, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces the Presentation of New Data on Products and Pipeline Programs at the Association for Research in Vision and Ophthalmology Meeting
April 20, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Reports More Than 65 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs
April 18, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3
April 17, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb and Heidelberg Engineering Announce the Introduction of SeeLuma™ Fully Digital Surgical Visualization Platform
April 13, 2023
From
Bausch + Lomb
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.